A U.S. Patent for a “Syringe Containing Stable Aqueous Formulations of Adalimumab” was awarded to Coherus Biosciences on May 14th, 2019. The present invention relates to aqueous pharmaceutical compositions suitable for long-term storage of adalimumab (including antibody proteins considered or intended as “biosimilar” or “bio-better” variants of commercially available adalimumab), methods of manufacture of the compositions, methods of their administration, and kits containing the same. Learn More